This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
IPC The Hospitalist Co Inc
IPCM : NASDAQ : Health Care
$43.08 0.90 | 2.13%
Today's Range: 41.91 - 43.30
Avg. Daily Volume: 163,100
11/20/14 - 4:00 PM ET

Financial Analysis


IPC THE HOSPITALIST CO INC's gross profit margin for the third quarter of its fiscal year 2014 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased. IPC THE HOSPITALIST CO INC has strong liquidity. Currently, the Quick Ratio is 1.56 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year.

During the same period, stockholders' equity ("net worth") has increased by 18.88% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q3 FY14 Q3 FY13
Net Sales ($mil)169.76149.07
EBITDA ($mil)18.0716.22
EBIT ($mil)16.715.07
Net Income ($mil)8.619.06


Balance Sheet Q3 FY14 Q3 FY13
Cash & Equiv. ($mil)25.4722.48
Total Assets ($mil)583.04458.55
Total Debt ($mil)70.045.0
Equity ($mil)355.84299.32


Profitability Q3 FY14 Q3 FY13
Gross Profit Margin27.2227.4
EBITDA Margin10.6410.88
Operating Margin9.8410.11
Sales Turnover1.161.28
Return on Assets6.698.79
Return on Equity10.9613.46
Debt Q3 FY14 Q3 FY13
Current Ratio1.661.75
Debt/Capital0.160.13
Interest Expense0.360.11
Interest Coverage46.25138.28


Share Data Q3 FY14 Q3 FY13
Shares outstanding (mil)17.2216.9
Div / share0.00.0
EPS0.490.52
Book value / share20.6717.71
Institutional Own % n/a n/a
Avg Daily Volume156337.0175252.0

Valuation


BUY. This stock's P/E ratio indicates a discount compared to an average of 27.32 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 19.78. To use another comparison, its price-to-book ratio of 1.89 indicates a discount versus the S&P 500 average of 2.73 and a significant discount versus the industry average of 3.74. The current price-to-sales ratio is well below the S&P 500 average, but above the industry average. Upon assessment of these and other key valuation criteria, IPC THE HOSPITALIST CO INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
IPCM 17.55 Peers 27.32   IPCM 15.40 Peers 15.17

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

IPCM is trading at a significant discount to its peers.

 

Average. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

IPCM is trading at a valuation on par to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
IPCM 15.59 Peers 19.45   IPCM NM Peers 2.43

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

IPCM is trading at a discount to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

IPCM's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
IPCM 1.89 Peers 3.74   IPCM -5.13 Peers 35.70

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

IPCM is trading at a significant discount to its peers.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, IPCM is expected to significantly trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
IPCM 0.99 Peers 0.77   IPCM 15.51 Peers 14.25

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

IPCM is trading at a significant premium to its industry.

 

Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.

IPCM is keeping pace with its peers on the basis of sales growth.

 

 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades


Top Rated Stocks Top Rated Funds Top Rated ETFs